Sp7 Mediated Control of Runx2 Function for Osteoblast Differentiation
Sp7介导的Runx2功能对成骨细胞分化的控制
基本信息
- 批准号:8220442
- 负责人:
- 金额:$ 32.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAffinityAnatomyAnimalsBMP2 geneBiochemicalBiologicalBiological ProcessBiologyBone DiseasesBone MatrixBone Morphogenetic ProteinsBone RegenerationBone TissueCartilageCartilage DiseasesCell Differentiation processCell MaturationCell modelCellsChondrocytesCleidocranial DysplasiaComplexCuesDNA BindingDNA Binding DomainDataDepositionDevelopmentDifferentiation and GrowthEmbryoErinaceidaeEventFailureFamilyFunctional disorderGene DeletionGene ExpressionGene Expression ProfileGene TargetingGenesGeneticGenetic TranscriptionGoalsGrowthHumanIn Situ HybridizationInheritedInnovative TherapyInterventionKnockout MiceKnowledgeMAP Kinase GeneMaintenanceMammalsMediatingMesenchymalMetabolic Bone DiseasesModelingModificationMolecularMolecular BiologyMonitorMusMutagenesisMutationNull LymphocytesOsteoblastsOsteogenesisPathway interactionsPatternPhenotypeProcessProtein BiochemistryProteinsRNARegulationResearchRoleRunx2 proteinSignal TransductionSkeletonSpecific qualifier valueSpecificitySubgroupTestingTissuesTo specifyUbiquitinUbiquitinationVertebratesWorkZinc Fingersbasebonebone cellimprovedin vivoinsightinterdisciplinary approachintramembranous bone formationmineralizationmorphogensmulticatalytic endopeptidase complexmutantnovelosteoblast differentiationosteogenicosteoprogenitor cellpreventprotein functionreconstitutionrepairedskeletalskeletal disorderskeletal tissueskeletogenesisstable cell linetranscription factorubiquitin ligase
项目摘要
DESCRIPTION (provided by applicant): Development of skeleton in mammals is an exceedingly complex process and involves both intramembranous and endochondral ossification. Completion of either class of ossification implies a highly intricate but well coordinated process of patterning, cell fate commitment, differentiation, growth and remodeling. These events are specified by a coordinated temporal and spatial pattern of gene expression. At first, secreted morphogens such as bone morphogenetic proteins, hedgehog, wingless proteins and others, signal to key transcription factors to specify gene expression. Runx2 is an essential transcription factor for chondrocyte and osteoblast differentiation. Runx2 gene deletion results in complete failure of skeleton formation and embryonic lethality. In humans, mutation of Runx2 gene causes cleidocranial dysplasia, a dominantly inherited skeletal disorder. Other master regulator of skeletogenesis is the Specificity protein-7 (Sp7). Sp7 belongs to the Sp subgroup of the Kruppel-like family of transcription factors characterized by three zinc-finger DNA-binding domains. Targeted disruption of Sp7/Osterix gene, results in absence of endochondral and intramembranous bone formation. The Sp7 deficient mesenchymal cells do not deposit bone matrix and cannot differentiate into osteoblasts. Very little is known about the underlying molecular mechanism for the surprisingly similar phenotype from the two seemingly unrelated proteins. Runx2 is required for the expression of Sp7 and possibly for its function as mice with targeted disruption of Runx2 do not show expression of Sp7. Interestingly, Runx2 expression is normal in the mesenchymal cells of membranous and the endochondral skeleton of Sp7 null animals. The functional incompetency of Runx2 in Sp7 deficient cells, suggest that Sp7 presence is obligatory for completion of Runx2 osteogenic activity. It is important to note that the observation of Runx2 presence in Sp7 null mice is limited to only RNA, determined by in situ hybridization of tissue section from Sp7 null embryos. Our recent data demonstrate that in skeletal cells, Sp7 acts as a molecular rheostat and is necessary for functional stability and turnover of Runx2 protein. Given that a complex post-transcription regulatory network is operative in skeletal cells, a strong possibility exist that Runx2 protein is never made or rapidly degraded in Sp7 null cells. We will experimentally address this by assessing endogenous levels of Runx2 protein in Sp7 null cells and by a regulated and selective gene reconstitution/ ablation in osteoprogenitor cells. The goal of this application is to identify and define a) spatial and temporal organization and assembly of Runx2 and Sp7 regulatory complexes for formation/maintenance of osteoblasts and b) mechanisms supporting stable complex formation and retention of competency for skeletal gene expression. Knowledge obtained from this study will provide molecular insights into components of bone regulatory complex that can be targeted for innovative therapy to improve cartilage and bone formation and repair.
PUBLIC HEALTH RELEVANCE: Crucial understanding of molecular mechanism involved in the regulation of bone cell maturation has significant potential for developing interventional therapies in growth anomalies and metabolic bone disorders. Findings from this study will help us in understanding the pathophysiology of skeletal tissues and cartilage and bone disorders.
描述(申请人提供):哺乳动物骨骼的发育是一个极其复杂的过程,涉及膜内和软骨内成骨。任何一类骨化的完成都意味着一个高度复杂但协调良好的图案化、细胞命运承诺、分化、生长和重塑过程。这些事件是由基因表达的协调的时间和空间模式指定的。首先,分泌的形态发生蛋白如骨形态发生蛋白、刺猬、无翼蛋白等,向关键转录因子发出信号,以指定基因表达。Runx2是软骨细胞和成骨细胞分化所必需的转录因子。Runx2基因缺失导致骨骼形成完全失败和胚胎死亡。在人类中,Runx2基因的突变会导致锁骨颅骨发育不良,这是一种显性遗传性骨骼疾病。骨骼形成的另一个主要调节因子是特异性蛋白-7(SP7)。SP7属于Kruppel类转录因子家族中的Sp亚类,具有三个锌指DNA结合区。靶向破坏SP7/Osterix基因,导致软骨内和膜内骨形成缺失。SP7缺陷的间充质细胞不沉积骨基质,不能分化为成骨细胞。对于这两个看似不相关的蛋白质产生惊人相似表型的潜在分子机制,人们知之甚少。Runx2是SP7表达所必需的,也可能是其功能所必需的,因为靶向干扰Runx2的小鼠不显示SP7的表达。有趣的是,在SP7缺失动物的膜间充质细胞和软骨内骨骼中,Runx2的表达是正常的。在SP7缺陷的细胞中,Runx2的功能不全,提示SP7的存在是完成Runx2成骨活性的必要条件。值得注意的是,在SP7缺失小鼠中观察到Runx2的存在仅限于RNA,这是通过SP7缺失胚胎组织切片的原位杂交确定的。我们最近的数据表明,在骨骼细胞中,SP7作为一个分子变阻器,对Runx2蛋白的功能稳定性和周转是必需的。鉴于复杂的转录后调控网络在骨骼细胞中起作用,很有可能Runx2蛋白在SP7缺失细胞中永远不会产生或迅速降解。我们将在实验中通过评估SP7缺失细胞中Runx2蛋白的内源性水平,以及在骨祖细胞中调节和选择性的基因重建/消融来解决这个问题。本应用的目标是识别和定义a)Runx2和SP7调控复合体的时空组织和组装,以形成/维持成骨细胞,以及b)支持稳定的复合体形成和保持骨骼基因表达的能力的机制。从这项研究中获得的知识将为骨调节复合体的成分提供分子洞察力,这些成分可以被靶向创新治疗,以改善软骨和骨的形成和修复。
公共卫生相关性:对参与骨细胞成熟调控的分子机制的关键了解,对于开发生长异常和代谢性骨疾病的介入治疗具有重要的潜力。这项研究的结果将有助于我们了解骨骼组织和软骨及骨骼疾病的病理生理学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amjad Javed其他文献
Amjad Javed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amjad Javed', 18)}}的其他基金
Osteoblasts Role in Dysfunction of Body Adiposity and Bone Metabolism
成骨细胞在身体肥胖和骨代谢功能障碍中的作用
- 批准号:
10255860 - 财政年份:2020
- 资助金额:
$ 32.19万 - 项目类别:
Dental Academic Research Training Program (DART)
牙科学术研究培训计划 (DART)
- 批准号:
10207586 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Dental Academic Research Training Program (DART)
牙科学术研究培训计划 (DART)
- 批准号:
10657808 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Dental Academic Research Training Program (DART)
牙科学术研究培训计划 (DART)
- 批准号:
10207587 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Sp7 Mediated Control of Runx2 Function for Osteoblast Differentiation
Sp7介导的Runx2功能对成骨细胞分化的控制
- 批准号:
8611706 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Sp7 Mediated Control of Runx2 Function for Osteoblast Differentiation
Sp7介导的Runx2功能对成骨细胞分化的控制
- 批准号:
9981286 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Sp7 Mediated Control of Runx2 Function for Osteoblast Differentiation
Sp7介导的Runx2功能对成骨细胞分化的控制
- 批准号:
8427272 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Dental Academic Research Training Program (DART)
牙科学术研究培训计划 (DART)
- 批准号:
10657823 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Sp7 Mediated Control of Runx2 Function for Osteoblast Differentiation
Sp7介导的Runx2功能对成骨细胞分化的控制
- 批准号:
10359695 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
Dental Academic Research Training Program (DART)
牙科学术研究培训计划 (DART)
- 批准号:
10526909 - 财政年份:2012
- 资助金额:
$ 32.19万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 32.19万 - 项目类别:
Research Grant